Gain Therapeutics shares owned by Vanguard Group
Quarter-by-quarter ownership of Gain Therapeutics (GANX) shares owned by Vanguard Group
from 13F filings
Historical chart of Vanguard Group investment in Gain Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Gain Therapeutics held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Gain Therapeutics by Vanguard Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $946k | 534k | 1.77 |
| 2025-06-30 | $962k | 534k | 1.80 |
| 2025-03-31 | $487k | 255k | 1.91 |
| 2024-12-31 | $383k | 177k | 2.16 |
| 2024-09-30 | $259k | 145k | 1.78 |
| 2024-06-30 | $186k | 145k | 1.28 |
| 2024-03-31 | $450k | 119k | 3.77 |
| 2023-12-31 | $289k | 88k | 3.27 |
| 2023-09-30 | $231k | 70k | 3.28 |
| 2023-06-30 | $287k | 64k | 4.48 |
| 2023-03-31 | $254k | 53k | 4.82 |